Skip to main content
Download PDF

Correction to: A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome

Pilot and Feasibility Studies volume 6, Article number: 67 (2020) Cite this article

The Original Article was published on 25 April 2020

Correction to: Pilot Feasibility Stud 6, 52 (2020)

https://doi.org/10.1186/s40814-020-00594-1

Following publication of the original article [1], the authors opted to correct the last name of co-author Susan Kahn from Khan to Kahn.

Reference

  1. Legault K, Blostein M, Carrier M, et al. A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome. Pilot Feasibility Stud. 2020;6:52 https://doi.org/10.1186/s40814-020-00594-1.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, McMaster University, 1280 Main St. W, Hamilton, ON, L8S 4L8, Canada

    Kimberly Legault, Sam Schulman & Mark A. Crowther

  2. Department of Medicine, McGill University, 845 Sherbrooke St. W, Montreal, QC, Canada

    Mark Blostein & Susan Kahn

  3. Department of Medicine, University of Ottawa, 75 Laurier Ave E, Ottawa, ON, Canada

    Marc Carrier

  4. Department of Medicine, Dalhousie University, 6299 South St, Halifax, NS, Canada

    Sudeep Shivakumar

  5. Department of Medicine, University of Alberta, 116 St & 85 Ave, Edmonton, AB, Canada

    Cynthia Wu

Authors
  1. Kimberly Legault
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mark Blostein
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marc Carrier
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Susan Kahn
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sam Schulman
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sudeep Shivakumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Cynthia Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Mark A. Crowther
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kimberly Legault.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Legault, K., Blostein, M., Carrier, M. et al. Correction to: A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome. Pilot Feasibility Stud 6, 67 (2020). https://doi.org/10.1186/s40814-020-00614-0

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s40814-020-00614-0

Pilot and Feasibility Studies

ISSN: 2055-5784